Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. Consensus
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
285.51 USD   -0.15%
12/02Weekly market update : One step forward, one step back
MS
12/02Amgen : Announcement for the purposes of rule 2.12 of the irish takeover panel act
PU
12/02Is the job report good or bad news?
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on AMGEN INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) AMGEN INC.
Analyst Recommendations on AMGEN INC.
11/18Credit Suisse Starts Amgen at Underperform With $240 PT, Says Recent Performance Not Refle..
MT
11/18Analyst recommendations: AbbVie, Bristol-Myers, Dominion Energy, Pfizer, Walgreens Boots....
MS
11/09DA Davidson Adjusts Amgen Price Target to $310 From $275, Maintains Buy Rating
MT
11/08Oppenheimer Adjusts Amgen Price Target to $300 From $290, Maintains Outperform Rating
MT
11/07UBS Adjusts Amgen Price Target to $271 From $257, Maintains Neutral Rating
MT
11/04Morgan Stanley Adjusts Price Target on Amgen to $282 From $279, Maintains Overweight Ratin..
MT
11/04Piper Sandler Boosts Price Target on Amgen to $278 From $265, Reiterates Overweight Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 285,51 $
Average target price 257,61 $
Spread / Average Target -9,77%
High Price Target 325,00 $
Spread / Highest target 13,8%
Low Price Target 180,00 $
Spread / Lowest Target -37,0%
Consensus detail
Consensus revision (last 18 months)